Application of physiologically based (PBK) modeling to quantify the effect of the antibiotic tobramycin on bile acid levels in human plasma
- PMID: 39731603
- DOI: 10.1007/s00204-024-03936-7
Application of physiologically based (PBK) modeling to quantify the effect of the antibiotic tobramycin on bile acid levels in human plasma
Abstract
Systemic bile acid homeostasis plays an important role in human health. In this study, a physiologically based kinetic (PBK) model that includes microbial bile acid deconjugation and intestinal bile acid reuptake via the apical sodium-dependent bile acid transporter (ASBT) was applied to predict the systemic plasma bile acid concentrations in human upon oral treatment with the antibiotic tobramycin. Tobramycin was previously shown to inhibit intestinal deconjugation and reuptake of bile acids and to affect bile acid homeostasis upon oral exposure of rats. Kinetic parameters to define the effects of tobramycin on intestinal bile acid transport were determined in vitro using a Caco-2 cell layer Transwell model for studying the intestinal translocation of 4 model bile acids including glycochenodeoxycholic acid (GCDCA), glycocholic acid (GCA), glycodeoxycholic acid (GDCA), and deoxycholic acid (DCA), the latter as a model for unconjugated bile acids (uBA). Kinetic constants for the effect of tobramycin on intestinal microbial deconjugation were taken from previous in vitro studies using anaerobic fecal incubations. The PBK model simulations predicted that exposure to tobramycin at the dose level also used in the previous 28 day rat study would reduce human plasma Cmax levels of GCA, GCDCA, GDCA, and DCA by 42.4%, 27.7%, 16.9%, and 75.8%. The reduction of conjugated bile acids is governed especially via an effect on ASBT-mediated intestinal uptake, and not via the effect of tobramycin on intestinal conjugation, likely because deconjugation happens to a large extent in the colon which has limited subsequent bile acid reuptake. The results reflect that oral exposure to xenobiotics that are not or poorly bioavailable can affect systemic bile acid homeostasis. Altogether, the PBK model appears to provide a 3R compliant tool to evaluate the effect of oral exposure to xenobiotics on host bile acid homeostasis via effects on intestinal bile acid deconjugation and reuptake.
Keywords: Apical sodium-dependent bile acid transporter (ASBT); Bile acids; Caco-2 cells; Physiologically based kinetic (PBK) model; Tobramycin.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare that they have no conflict of interest.
Similar articles
-
Intestinal in vitro transport assay combined with physiologically based kinetic modeling as a tool to predict bile acid levels in vivo.ALTEX. 2024 Jan 9;41(1):20-36. doi: 10.14573/altex.2302011. Epub 2023 Jul 27. ALTEX. 2024. PMID: 37528756
-
Antibiotics reduce intestinal bile acid reuptake in an in vitro model system.Toxicol In Vitro. 2025 Aug;107:106071. doi: 10.1016/j.tiv.2025.106071. Epub 2025 Apr 9. Toxicol In Vitro. 2025. PMID: 40216036
-
In vitro models to detect in vivo bile acid changes induced by antibiotics.Arch Toxicol. 2022 Dec;96(12):3291-3303. doi: 10.1007/s00204-022-03373-4. Epub 2022 Sep 8. Arch Toxicol. 2022. PMID: 36074177 Free PMC article.
-
Role of the intestinal bile acid transporters in bile acid and drug disposition.Handb Exp Pharmacol. 2011;(201):169-203. doi: 10.1007/978-3-642-14541-4_4. Handb Exp Pharmacol. 2011. PMID: 21103970 Free PMC article. Review.
-
An important intestinal transporter that regulates the enterohepatic circulation of bile acids and cholesterol homeostasis: The apical sodium-dependent bile acid transporter (SLC10A2/ASBT).Clin Res Hepatol Gastroenterol. 2017 Oct;41(5):509-515. doi: 10.1016/j.clinre.2017.02.001. Epub 2017 Mar 21. Clin Res Hepatol Gastroenterol. 2017. PMID: 28336180 Review.
References
-
- Bathena SPR, Mukherjee S, Olivera M, Alnouti Y (2013) The profile of bile acids and their sulfate metabolites in human urine and serum. J Chromatogr B 942:53–62 - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical